## **Core Concept**
Ovarian cancer staging is based on the International Federation of Gynecology and Obstetrics (FIGO) classification, which describes the extent of spread of the tumor. The staging system ranges from Stage I (tumor limited to ovaries) to Stage IV (distant metastasis). Understanding the FIGO staging system is crucial for determining prognosis and treatment.

## **Why the Correct Answer is Right**
The correct answer, Stage IV, is appropriate for ovarian cancer with superficial liver metastasis and bilateral ovarian masses. According to the FIGO staging system:
- Stage I: Tumor limited to ovaries.
- Stage II: Tumor involves one or both ovaries with pelvic extension.
- Stage III: Tumor involves one or both ovaries with histologically confirmed peritoneal implants outside the pelvis and/or regional lymph node metastasis.
- **Stage IV**: Distant metastasis. This includes parenchymal metastases to organs such as the liver.

Superficial liver metastasis indicates that the cancer has spread to the liver's surface, which falls under the category of distant metastasis.

## **Why Each Wrong Option is Incorrect**
- **Option A (Stage I):** This stage is incorrect because it implies the tumor is limited to the ovaries, which does not match the scenario of superficial liver metastasis.
- **Option B (Stage II):** This stage involves ovarian tumor with pelvic extension but does not account for distant metastasis like liver involvement.
- **Option C (Stage III):** While this stage involves peritoneal implants outside the pelvis or regional lymph node metastasis, it does not include distant organ metastasis like liver involvement.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the FIGO staging system for ovarian cancer is primarily based on surgical findings. The presence of distant metastasis, such as to the liver, automatically classifies the cancer as Stage IV, which significantly impacts treatment planning and prognosis.

## **Correct Answer: D. Stage IV.**